Our CEO, Nicolas Wolikow, and our Patients’ Committee Manager, Yann Bizien, recently spoke on Public Sénat about the Rosalind Study and our Patients’ Committee, addressing the alarming rise of early-onset Cancer in France and worldwide.
As Cancer rates among people under 50 continue to increase, the segment explores the public health response, ongoing oncology research, and the need for a national Cancer registry to better understand, anticipate and prevent this growing public health challenge.
Credit: Public Sénat
—-
Why does France have some of the highest Cancer rates in the world? Since 1990, warning signals have been multiplying, affecting increasingly younger age groups. Worldwide, the number of new early-onset Cancer cases has surged by nearly 80% in less than 30 years. In France alone, around 400,000 new Cancer cases are diagnosed every year.
How can this alarming trend be explained? What measures are being taken to curb the growing epidemic of early-onset Cancers affecting people under the age of 50? In France, doctors and researchers are mobilizing to address this major public health challenge.
In Parliament, centrist senator Sonia de la Provôté from Calvados drafted a bill to create a national Cancer registry. Unanimously adopted by the Senate in June 2023, the bill was definitively passed two years later by the National Assembly. The objective is clear: to improve Cancer data collection and better understand the scale and causes of Cancer in France.
—
Credit: Public Sénat
Nicolas Wolikow, CEO
Updated: Jan 29, 2026
